Johnson & Johnson
JNJ
$167.33
$2.591.57%
NYSE
| 06/29/2025 | 03/30/2025 | 12/29/2024 | 09/29/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 90.63B | 89.33B | 88.82B | 87.70B | 86.58B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 90.63B | 89.33B | 88.82B | 87.70B | 86.58B |
| Cost of Revenue | 28.53B | 27.78B | 27.04B | 26.64B | 26.27B |
| Gross Profit | 62.10B | 61.55B | 61.79B | 61.05B | 60.31B |
| SG&A Expenses | 22.21B | 21.91B | 21.95B | 21.29B | 21.18B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.79B | 66.56B | 66.18B | 64.30B | 62.31B |
| Operating Income | 22.84B | 22.77B | 22.65B | 23.39B | 24.27B |
| Income Before Tax | 27.35B | 26.60B | 16.69B | 17.63B | 19.51B |
| Income Tax Expenses | 4.69B | 4.79B | 2.62B | 2.86B | 3.12B |
| Earnings from Continuing Operations | 22.66K | 21.81K | 14.07K | 14.77K | 16.38K |
| Earnings from Discontinued Operations | -- | -- | -- | -83.00M | 21.64B |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.66B | 21.81B | 14.07B | 14.68B | 38.02B |
| EBIT | 22.84B | 22.77B | 22.65B | 23.39B | 24.27B |
| EBITDA | 30.29B | 30.07B | 29.98B | 30.30B | 31.15B |
| EPS Basic | 9.40 | 9.05 | 5.83 | 5.88 | 15.08 |
| Normalized Basic EPS | 6.27 | 6.34 | 6.27 | 6.44 | 6.52 |
| EPS Diluted | 9.35 | 8.99 | 5.79 | 5.84 | 14.94 |
| Normalized Diluted EPS | 6.23 | 6.30 | 6.23 | 6.40 | 6.48 |
| Average Basic Shares Outstanding | 9.65B | 9.65B | 9.65B | 9.99B | 10.10B |
| Average Diluted Shares Outstanding | 9.70B | 9.70B | 9.71B | 10.05B | 10.17B |
| Dividend Per Share | 5.02 | 4.96 | 4.91 | 4.86 | 4.81 |
| Payout Ratio | 53.34% | 54.76% | 84.05% | 79.71% | 22.93% |